XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Total revenues $ 68,164 $ 50,790
Operating expenses:    
Cost of sales - product 13,769 10,966
Research and development 19,377 13,528
Selling, general and administrative 47,678 44,065
Bad debt expense 10,970 0
Total operating expenses 91,794 68,559
Loss from operations (23,630) (17,769)
Other income (expense):    
Interest income 7,739 9,468
Interest expense (1,692) (1,695)
Sublease income (expense) (Note 5) 2,226 (1,602)
Loss on debt extinguishment (82,095) 0
Other (loss) income (423) 101
Net loss before income taxes (97,875) (11,497)
Benefit from income taxes 1,776 2,776
Net loss $ (96,099) $ (8,721)
Net loss per share attributable to common stockholders    
Basic (in USD per share) $ (0.77) $ (0.07)
Diluted (in USD per share) $ (0.77) $ (0.07)
Weighted-average shares used in computing net loss per share attributable to common stockholders:    
Basic (in shares) 124,871 130,200
Diluted (in shares) 124,871 130,200
Product revenue, net    
Revenues:    
Total revenues $ 64,959 $ 47,845
Other revenue    
Revenues:    
Total revenues $ 3,205 $ 2,945